☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Drug Safety Update, Issue 7

The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update Issue 7 (PDF).

This issue includes the following drug safety advice articles:

  • Statins: class effects identified
  • Varenicline: safety update
  • Carisoprodol and meprobamate: risks outweigh benefits

In addition, this issue contains stop press reminders about the withdrawal of dydrogesterone (Duphaston/Duphaston HRT®) for commercial reasons and the new contraindications and warnings added to the prescribing information for rosiglitazone.

Action: Clinicians will find this publication to be a useful review of current issues in drug safety.

Share 'Drug Safety Update, Issue 7' by emailShare 'Drug Safety Update, Issue 7' on FacebookShare 'Drug Safety Update, Issue 7' on TwitterShare 'Drug Safety Update, Issue 7' on LinkedInShare 'Drug Safety Update, Issue 7' on reddit


No Comments to “Drug Safety Update, Issue 7”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.